NEW YORK, Jan. 11 (GenomeWeb News) - The US Food and Drug Administration has cleared the second of two genes in Roche Diagnostic's AmpliChip CYP450 test, clearing the way for the device to be sold as an in vitro diagnostic in the United States, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.